VP of Medical Affairs
Mirvie Inc
Carrie Haverty, MS, CGC is Vice President of Medical Affairs at Mirvie, where she leads clinical strategy and medical affairs for novel diagnostics advancing proactive, personalized, and predictive maternal care. She provides clinical and scientific oversight across Mirvie’s product portfolio, bridging translational biology, clinical evidence generation, and real-world implementation in obstetrical care.
A board-certified genetic counselor, Carrie currently serves as President of the National Society of Genetic Counselors, bringing a national leadership perspective as a non-physician clinician shaping the future of women’s health innovation. She began her career in high-risk prenatal care with a focus on expanding access to emerging diagnostic technologies and led clinical teams at Massachusetts General Hospital and Sutter Health.
Her direct patient-care experience has been foundational to the development and successful commercialization of leading women’s health diagnostics at Counsyl, Myriad, and Mirvie.